IL-11 Is Required for A(1) Adenosine Receptor–Mediated Protection against Ischemic AKI

A(1) adenosine receptor activation ameliorates ischemic AKI through the induction of renal proximal tubular sphingosine kinase-1. However, systemic adverse effects may limit A(1) adenosine receptor–based therapy for ischemic AKI, indicating a need to identify alternative therapeutic targets within t...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Kim, Joo Yun, Kim, Mihwa, Ham, Ahrom, Brown, Kevin M., Greene, Robert W., D’Agati, Vivette D., Lee, H. Thomas
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society of Nephrology 2013
Pynciau:
Basic Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3785280/
https://ncbi.nlm.nih.gov/pubmed/23813214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2013010114
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg